Routine childhood immunisation programme
Uptake in North Tyneside for the routine childhood programme remains among the highest in England. The Northeast also has the highest coverage in England. In 2021/22 coverage for routine childhood immunisation programme in North Tyneside is presented in table 3 below.
Achieving population coverage of >95% is important as this is the point at which the entire population is protected, including the 5% that are not vaccinated. This is referred to as herd immunity.
Table 3: Coverage routine childhood immunisation programme for children 0-5 years North Tyneside 2021/22
| Vaccine and booster programme | Age cohorts | |||||
|---|---|---|---|---|---|---|
| 12 months | 24 months | 5 years | ||||
| England | NT | England | NT | England | NT | |
| Diphtheria, tetanus, pertussis, polio, haemophilus influenza type b (DTaP/IPV/Hib) |
91.8% |
97.0% |
93.0%* |
97.7%* |
94.4% |
97.2% |
| Men B |
91.5% |
97.3% |
||||
| Rotavirus |
89.9% |
95.9% |
||||
| PCV |
93.8% |
97.7% |
89.3%* |
96.5 %* |
||
| MenC/Hib (booster) |
89.0%* |
96.9%* |
91.7% |
95.6 |
||
| Measles, mumps, and rubella (MMR) One dose |
89.2% |
96.9% |
93.4%** |
97.0%** |
||
| Measles, mumps, and rubella (MMR) Two dose |
85.7% |
94.0% |
||||
| DTaP/IPV* |
94.2% |
97.2% |
||||
|
<90% Coverage |
90% to 95% Coverage |
≥95% Coverage |
*Boosters 21/22 ** Two doses MMR
North Tyneside achieves a coverage rate of >95% for all the childhood immunisation programmes, except for two doses of MMR at 5 years of age.
Table 4: Coverage routine childhood immunisation HPV and Td/IPV and MenACWY Booster
| Vaccine and booster programmes | Age Cohorts | |||||||
|---|---|---|---|---|---|---|---|---|
|
Year 8 – HPV (1 & 2 doses) Year 9 - Td/IPV |
HPV – Year 9 (1 & 2 doses) Td/IPV & MenACWY – 13-14 & 14-15 yrs. |
|||||||
| England | North Tyneside | England | North Tyneside | |||||
| 1 Dose | 2 Doses | 1 dose | 2 Doses | 1 dose | 2 Doses | 1 dose | 2 Doses | |
| HPV (females) 21/22 | 69.6% | 10.7% | 80.9% | N/A | 82.2% | 60.6% | 78.5% | 67.3% |
| HPV (males) (21/22) | 62.4% | 80% | 78% | 62.4% | 73% | 58.1% | ||
| Td/IPV (20/21) | N/A | 86.4% | 80.3% | 76.4% | 89.4% | 86.4% | ||
| MenACWY (20/21) | N/A | N/A | 80.9% | 76.5% | 87.4% | 90.0% | ||
All girls aged 12 to 13 are offered HPV (human papilloma virus) vaccination as part of the childhood vaccination programme. The vaccine protects against cervical cancer. It is usually given to girls in years 8 and 9 within schools in England with a second dose administered within 6 to 12 months (this can also occur in either year 8 or year 9). In North Tyneside the coverage for the one dose at year 8 and 9 respectively was 80.9% and 78.5% compared to 69.6% and 82.2% in England (2021/22).
In September 2019 the HPV vaccination programme was be extended to all pupils in year 8, including boys. The programme is in the early phases locally which explains the overall uptake. Td/IPV (tetanus, diphtheria, and polio) teenage booster is the final dose of the routine childhood immunisation programme. Nationally many areas give the Td/IVP booster in school year 10. The national plan is to provide the Td/IPV booster in year 9 alongside the final MenC booster. At present data is presented for both year 9 and year 10 to reflect the current system.
Developments within the school age immunisation service (SAIS) will enable a more a detailed analysis of the school-based programmes in the coming years.